Potential Upswing for Overlooked Stocks This Earnings Season

Jeffries thinks that stocks which haven’t attracted much attention from Wall Street could see significant gains this earnings season. We’re heading into a busy week as the second quarter reports roll out. About 30% of the S&P 500, or 151 companies, are set to announce their latest revenue figures. Additionally, nine companies from the Dow Jones Industrial Average will also report their results this week. Notably, four out of the “Magnificent Seven” group are on the schedule, which could be quite impactful for the pharmaceutical and oil sectors.

Earlier, analysts from Jeffries released a note discussing stocks that Wall Street might have missed. They expressed optimism about upcoming revenue announcements and market reactions. “We are looking forward to future revenue releases and other key events in the near term,” the memo stated. Their analysis is based on various insights, including channel checks, ALT data reviews, calls with experts, and discussions with industry insiders, indicating that upcoming revenues and events could influence stock prices significantly.

While 2023 has seen a slowdown in progress due to investments in video podcast ventures, the overall revenue trend appears positive. Analysts suggest that they might exceed the 5 million subscriber estimate in Q2 2025. They will report their figures on Tuesday, with expectations of a stable production rate of 38 million. Each additional maximum could bring in an extra $10 million in free cash flow, according to analyst Sheila Kahiaglu.

Moreover, Jeffries pointed out Clorox, which is slated to release its fourth quarter results on Thursday. Clorox shares have dropped 19% this year. Analyst Kamil Gajrawala noted that analysts have set a price target of $145, anticipating stakeholders will see a boost ahead of Clorox’s July ERP transition, with stocks projected to be around 10% higher than Wednesday.